EveryLife Foundation sent a letter to CDC leadership outlining these concerns and urging action.
Related Articles
- FDA Rare Disease Roundtable – June 3, 2026
- EveryLife Foundation Urges CDC to Adopt Streamlined, Patient‑Centered Process for ICD‑10 Codes for Rare and Genetic Diseases
- The EveryLife Foundation submitted a statement to Congress urging lawmakers to support the inclusion of funding for the Rare Disease Innovation Hub
